Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia - Atropine for the Treatment of Myopia (WA-ATOM) study.
Samantha Sze-Yee LeeVinay Kumar NilagiriGareth LinghamMagdalena BlaszkowskaPaul G SanfilippoMaria FranchinaAntony ClarkDavid A MackeyPublished in: Clinical & experimental ophthalmology (2024)
These findings showed evidence of rapid myopia progression following cessation of 0.01% atropine. Further investigations are warranted to ascertain the long-term effects of atropine eyedrops.